Engine Capital Management, LP Harvard Bioscience Inc Transaction History

Engine Capital Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 17, 2020	SELL	$2.75 - $4.2 $248,107 - $378,928	-90,221 Closed	0 $0
Q2 2020 Aug 18, 2020	BUY	$2.12 - $3.14 $191,268 - $283,293	90,221 New	90,221 $280,000
Q2 2020 Aug 14, 2020	SELL	$2.12 - $3.14 $8.12 Million - $12 Million	-3,828,907 Closed	0 $0
Q1 2020 May 18, 2020	BUY	$1.42 - $3.29 $879,572 - $2.04 Million	619,417 Added 19.3%	3,828,907 $10.8 Million
Q4 2019 Feb 14, 2020	SELL	$2.45 - $3.25 $816,736 - $1.08 Million	-333,362 Reduced 9.41%	3,209,490 $9.79 Million
Q3 2019 Nov 15, 2019	BUY	$1.59 - $3.47 $2.66 Million - $5.81 Million	1,674,804 Added 89.66%	3,542,852 $10.5 Million
Q2 2019 Aug 15, 2019	BUY	$1.93 - $4.59 $3.61 Million - $8.57 Million	1,868,048 New	1,868,048 $3.74 Million

30.6M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Engine Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Engine Capital Management, LP with notifications on news.